2016 Q2 Form 10-Q Financial Statement

#000121465916011672 Filed on May 18, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q4
Revenue $10.00K $0.00
YoY Change -85.37% -100.0%
Cost Of Revenue $10.00K $0.00
YoY Change -72.28% -100.0%
Gross Profit $10.00K $0.00
YoY Change -69.04%
Gross Profit Margin 100.0%
Selling, General & Admin $920.0K $183.1K $1.040M
YoY Change 1043.6% 71.58% 121.28%
% of Gross Profit 9200.0%
Research & Development $170.0K $89.34K $220.0K
YoY Change -91.57% -25.79% -97.73%
% of Gross Profit 1700.0%
Depreciation & Amortization $10.00K $10.00K $30.00K
YoY Change -42.24% -42.24% 50.0%
% of Gross Profit 100.0%
Operating Expenses $1.080M $1.016M $1.260M
YoY Change -55.61% 148.27% -87.23%
Operating Profit -$1.070M -$1.016M -$1.260M
YoY Change -55.43% 152.12% -87.23%
Interest Expense $2.790M $1.000K $30.00K
YoY Change 11103.02% -96.69% -99.12%
% of Operating Profit
Other Income/Expense, Net -$500.6K
YoY Change -459.59%
Pretax Income $1.590M -$1.520M -$1.300M
YoY Change -265.63% 484.62% -79.78%
Income Tax $0.00
% Of Pretax Income
Net Earnings $1.590M -$1.516M -$1.300M
YoY Change -266.26% 475.16% -79.78%
Net Earnings / Revenue 15900.0%
Basic Earnings Per Share -$0.25
Diluted Earnings Per Share $14.45M -$0.25 -$10.83M
COMMON SHARES
Basic Shares Outstanding 7.312M shares 6.139M shares 5.977M shares
Diluted Shares Outstanding 6.139M shares

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.0K $610.0K $0.00
YoY Change -78.22% 771.43% -100.0%
Cash & Equivalents $220.0K $608.9K $4.152K
Short-Term Investments
Other Short-Term Assets $40.00K $0.00
YoY Change -77.78% -100.0%
Inventory $40.00K $48.81K $28.69K
Prepaid Expenses
Receivables $10.00K
Other Receivables $0.00
Total Short-Term Assets $270.0K $693.8K $32.84K
YoY Change -79.64% 91.45% -90.41%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $7.029K $7.838K
YoY Change -75.12% -87.78% -89.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $252.5K $296.5K
YoY Change -100.0% 79.47% 104.78%
Total Long-Term Assets $250.0K $259.5K $304.3K
YoY Change 41.43% 30.94% 38.58%
TOTAL ASSETS
Total Short-Term Assets $270.0K $693.8K $32.84K
Total Long-Term Assets $250.0K $259.5K $304.3K
Total Assets $520.0K $953.3K $337.2K
YoY Change -65.4% 70.06% -40.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $690.0K $510.0K $650.0K
YoY Change -6.76% -90.79% -87.55%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $50.00K $50.00K $50.00K
YoY Change -94.79% -92.75%
Total Short-Term Liabilities $1.180M $4.101M $2.505M
YoY Change 59.42% -39.72% -59.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.180M $4.101M $2.505M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.180M $4.100M $2.510M
YoY Change -69.92% -68.47% -80.22%
SHAREHOLDERS EQUITY
Retained Earnings -$41.51M -$40.00M
YoY Change 9.36% 6.11%
Common Stock $6.586K $5.977K
YoY Change -98.05% 65.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $113.4K $113.4K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$650.0K -$3.148M -$2.168M
YoY Change
Total Liabilities & Shareholders Equity $520.0K $953.3K $337.2K
YoY Change -65.4% 70.06% -40.01%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income $1.590M -$1.516M -$1.300M
YoY Change -266.26% 475.16% -79.78%
Depreciation, Depletion And Amortization $10.00K $10.00K $30.00K
YoY Change -42.24% -42.24% 50.0%
Cash From Operating Activities -$430.0K -$580.0K -$280.0K
YoY Change 4.88% 346.15% 211.11%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $36.08K
YoY Change
Cash From Investing Activities $40.00K -$40.00K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.220M 0.000
YoY Change -100.0% 771.43% -100.0%
NET CHANGE
Cash From Operating Activities -430.0K -580.0K -280.0K
Cash From Investing Activities 40.00K -40.00K 0.000
Cash From Financing Activities 0.000 1.220M 0.000
Net Change In Cash -390.0K 600.0K -280.0K
YoY Change -141.49% 5900.0% -566.67%
FREE CASH FLOW
Cash From Operating Activities -$430.0K -$580.0K -$280.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$430.0K -$280.0K
YoY Change 4.88% 211.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">Recently Issued Accounting Pronouncements Not Yet Adopted</font></font></div> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"> <div style="TEXT-INDENT: 0pt; DISPLAY: block;">&#160;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">As of March 31, 2016, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements through 2017.</font></div></div></div>
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Trading Symbol
TradingSymbol
VRME
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
VerifyMe, Inc.
CY2016Q1 vrme Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable And Expected To Vest Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableAndExpectedToVestIntrinsicValue
463000 USD
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
463000 USD
CY2016Q1 vrme Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1
463000 USD
CY2015Q4 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
9.67
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredWeightedAverageExercisePrice
0.85
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
0.40
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
3.31
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2016Q1 us-gaap Share Price
SharePrice
0.55
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable And Expected To Vest Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableAndExpectedToVestWeightedAverageExercisePrice
3.31
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
10335 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
19369 USD
CY2015Q1 vrme Fair Value Of Options Issued In Exchange For Services
FairValueOfOptionsIssuedInExchangeForServices
-54834 USD
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001104038
CY2016Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
335827 USD
CY2015Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
-54834 USD
CY2016Q1 us-gaap Shareholders Equity Fair Value Disclosure
ShareholdersEquityFairValueDisclosure
-82125 USD
CY2016Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
15275 USD
CY2016Q1 us-gaap Share Price
SharePrice
0.65
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
15000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
35000 USD
CY2016Q1 vrme Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings Warrant Liability
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsWarrantLiability
1767576 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
1235000 USD
CY2016Q1 vrme Accretion Of Discount On Preferred Stock As Deemed Dividend Distribution
AccretionOfDiscountOnPreferredStockAsDeemedDividendDistribution
1235000 USD
CY2016Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
1698000 USD
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17500 USD
CY2016Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0 USD
CY2016Q1 vrme Assets And Liabilities Measured At Fair Value On Nonrecurring Basis
AssetsAndLiabilitiesMeasuredAtFairValueOnNonrecurringBasis
0 USD
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1802375 USD
CY2016Q1 vrme Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings Embedded Derivative
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsEmbeddedDerivative
1235000 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1267933 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3537018 USD
CY2016Q1 vrme Convertible Preferred Stock Effective Conversion Price
ConvertiblePreferredStockEffectiveConversionPrice
CY2016Q1 vrme Intrinsic Value Of Conversion Option Per Share
IntrinsicValueOfConversionOptionPerShare
0.55
CY2016Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 USD
CY2016Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 USD
CY2016Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2016Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
15275 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
335828 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
USD
CY2016Q1 vrme Adjustment To Additional Paid In Capital Amortization Of Deferred Compensation
AdjustmentToAdditionalPaidInCapitalAmortizationOfDeferredCompensation
202691 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
-3148220 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1516334 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-263636 USD
CY2016Q1 vrme Fair Value Of Options Issued In Exchange For Services
FairValueOfOptionsIssuedInExchangeForServices
335828 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7838 USD
CY2016Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
15275 USD
CY2015Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
CY2016Q1 us-gaap Accretion Of Discount
AccretionOfDiscount
USD
CY2015Q1 us-gaap Accretion Of Discount
AccretionOfDiscount
10447 USD
CY2016Q1 vrme Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
36643 USD
CY2015Q1 vrme Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
-169476 USD
CY2016Q1 vrme Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
463000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7644 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21426 USD
CY2016Q1 vrme Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
202691 USD
CY2015Q1 vrme Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20120 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2632 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-101305 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
346205 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6250 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-576678 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-125486 USD
CY2016Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
36083 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36083 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2015Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
136102 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
1235000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1217500 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
136102 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
604739 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10616 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4152 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63956 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
608891 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74572 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2016Q1 vrme Security Deposit Offset Against Accounts Payable
SecurityDepositOffsetAgainstAccountsPayable
37197 USD
CY2015Q1 vrme Security Deposit Offset Against Accounts Payable
SecurityDepositOffsetAgainstAccountsPayable
USD
CY2015Q1 vrme Accretion Of Discount On Preferred Stock As Deemed Dividend Distribution
AccretionOfDiscountOnPreferredStockAsDeemedDividendDistribution
USD
CY2016Q1 vrme Revaluation Of Restricted Stock Units Between Additional Paid In Capital And Deferred Compensation
RevaluationOfRestrictedStockUnitsBetweenAdditionalPaidInCapitalAndDeferredCompensation
82125 USD
CY2015Q1 vrme Revaluation Of Restricted Stock Units Between Additional Paid In Capital And Deferred Compensation
RevaluationOfRestrictedStockUnitsBetweenAdditionalPaidInCapitalAndDeferredCompensation
USD
CY2016Q1 us-gaap Inventory Net
InventoryNet
48807 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
28687 USD
CY2016Q1 vrme Employee Advances Current
EmployeeAdvancesCurrent
36083 USD
CY2015Q4 vrme Employee Advances Current
EmployeeAdvancesCurrent
USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
693781 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
32839 USD
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
231430 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
230621 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7029 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
6250 USD
CY2015Q4 us-gaap Assets
Assets
337168 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
514471 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
652973 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
CY2016Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
USD
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
37197 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
173729 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
166894 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
252459 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
259294 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
252459 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
296491 USD
CY2016Q1 us-gaap Assets
Assets
953269 USD
CY2016Q1 us-gaap Notes Payable Current
NotesPayableCurrent
50000 USD
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
50000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
USD
CY2016Q1 vrme Warrant Liability Current
WarrantLiabilityCurrent
1839018 USD
CY2015Q4 vrme Warrant Liability Current
WarrantLiabilityCurrent
1802375 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4101489 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2505348 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
6586 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5977 USD
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40027210 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39779414 USD
CY2016Q1 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
350540 shares
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
113389 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
113389 USD
CY2016Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
1557518 USD
CY2015Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
1842334 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41514624 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39998290 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-2168180 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
953269 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337168 USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
CY2016Q1 us-gaap Royalty Revenue
RoyaltyRevenue
USD
CY2015Q1 us-gaap Royalty Revenue
RoyaltyRevenue
6250 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
6250 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
117758 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83901 USD
CY2016Q1 us-gaap Professional Fees
ProfessionalFees
115345 USD
CY2015Q1 us-gaap Professional Fees
ProfessionalFees
11113 USD
CY2016Q1 vrme Payroll Expenses
PayrollExpenses
627923 USD
CY2015Q1 vrme Payroll Expenses
PayrollExpenses
170904 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89335 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
120386 USD
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
65331 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
139226 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22808 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
1015692 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
409112 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1015692 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-402862 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6139460 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y4M24D
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable And Expected To Vest Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableAndExpectedToVestWeightedAverageRemainingContractualTerms
P3Y4M24D
CY2016Q1 us-gaap Interest Expense
InterestExpense
1000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
30250 USD
CY2016Q1 vrme Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
1730933 USD
CY2015Q1 vrme Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
169476 USD
CY2015Q1 vrme Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
USD
CY2016Q1 vrme Fair Value Of Warrants In Excess Of Consideration For Convertible Preferred Stock
FairValueOfWarrantsInExcessOfConsiderationForConvertiblePreferredStock
1767575 USD
CY2015Q1 vrme Fair Value Of Warrants In Excess Of Consideration For Convertible Preferred Stock
FairValueOfWarrantsInExcessOfConsiderationForConvertiblePreferredStock
USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-500642 USD
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3618566 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6139460 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3618566 shares
CY2015Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
350540 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 vrme Convertible Preferred Stock Issued During Period Value New Issues
ConvertiblePreferredStockIssuedDuringPeriodValueNewIssues
1235000 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
17500 USD
CY2016Q1 vrme Adjustments To Additional Paid In Capital Deemed Dividend Distribution
AdjustmentsToAdditionalPaidInCapitalDeemedDividendDistribution
1235000 USD
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6937250 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6327570 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6586710 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5977030 shares
CY2016Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
23500 shares
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7312211 shares
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
4499452 shares
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAndExpectedToVest
4499452 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
2941 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4499452 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
3087500 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1414893 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y9M18D
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageRemainingContractualTerms
P3Y
CY2016Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms
P3Y4M24D

Files In Submission

Name View Source Status
0001214659-16-011672-index-headers.html Edgar Link pending
0001214659-16-011672-index.html Edgar Link pending
0001214659-16-011672.txt Edgar Link pending
0001214659-16-011672-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
ex3_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
l5916110q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrme-20160331.xml Edgar Link completed
vrme-20160331.xsd Edgar Link pending
vrme-20160331_cal.xml Edgar Link unprocessable
vrme-20160331_def.xml Edgar Link unprocessable
vrme-20160331_lab.xml Edgar Link unprocessable
vrme-20160331_pre.xml Edgar Link unprocessable